Viewing Study NCT00645268


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2026-02-21 @ 10:34 AM
Study NCT ID: NCT00645268
Status: COMPLETED
Last Update Posted: 2021-02-01
First Post: 2008-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A1481146
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators